Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730990 · ClinicalTrials.gov registry record · Phase 1
A Phase I, Healthy Volunteer Positron Emission Tomography Study
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00730990 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 10 participants.
The verdict
NCT00730990, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess central receptor occupancy of PF 03654746 at the H3 receptor after a single oral dose of PF 03654746.
Interventions
- OTHER Positron Emission tomography
- DRUG PET Scan with PF-03654746
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00730990
The ClinicalTrials.gov registry entry for NCT00730990 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Positron Emission tomography is the first listed.
NCT00730990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00730990 about?
NCT00730990 is a clinical study titled "A Phase I, Healthy Volunteer Positron Emission Tomography Study". The primary purpose of this study is to assess central receptor occupancy of PF 03654746 at the H3 receptor after a single oral dose of PF 03654746.
What is the current status of trial NCT00730990?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-05. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00730990?
The interventions under investigation include: Positron Emission tomography (OTHER), PET Scan with PF-03654746 (DRUG).
Who is sponsoring clinical trial NCT00730990?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.